Brenda Y. Varela, NP

Brenda Varela practices at Adventist Health Bakersfield in Bakersfield, California, part of Adventist Health.

Brenda Varela's NPI, 1356771745, was assigned on November 21, 2013. Brenda Varela holds California license 95000147.

Brenda Varela's primary practice is Adventist Health Bakersfield, at 2615 Chester Avenue, Bakersfield, CA 93301 in Kern County. The practice phone is (661) 395-3000.

Brenda Varela's primary practice is Adventist Health Bakersfield in Bakersfield, California, part of Adventist Health. Brenda Varela is also affiliated with Adventist Health Delano. The medical group on file is Adventist Health Bakersfield. Dmand AI also links Brenda Varela to 1 more hospital and 2 medical groups, each named with a free account. Brenda Varela's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Brenda Varela practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Brenda Varela's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Brenda Varela is licensed in California.

Dmand AI lists osteoporosis among the conditions Brenda Varela treats.

CMS data shows 330 Medicare services from Brenda Varela across 1 procedure code in 2024, all of them office visits, for 192 Medicare patients. Medicare paid $14,655 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Brenda Varela in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Brenda Varela's median patient age at 68, with 62% women.

In 2024, Brenda Varela wrote 625 Medicare Part D claims for 175 patients. 94% of them were for generic drugs. CMS names the drug for 407 of them, across 14 drugs with 11 or more claims each, at $164,083 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Brenda Varela for performance year 2024, reported as part of a group. Brenda Varela accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Brenda Varela as offering telehealth.

CMS Open Payments shows 28 general payments to Brenda Varela from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $99.